Poor glycaemic control caused by insulin induced lipohypertrophy
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Good glycaemic control reduces the risk of complications of diabetes.1 Secondary failure of oral hypoglycaemic treatment is common in patients with type 2 diabetes, and thus insulin treatment is often needed to improve glycaemic control. Indeed, in the UK prospective diabetes study 38% of patients with type 2 diabetes needed insulin treatment after 10 years.1 The reasons for poor glycaemic control are many; and despite insulin treatment many patients with diabetes have poor glycaemic control.2 Lipohypertrophy is characterised by a benign “tumour-like” swelling of fatty tissue secondary to subcutaneous insulin injections. We describe two cases in which poor glycaemic control was directly related to insulin induced lipohypertrophy, recognition of which led to major improvements in glycaemic control. ### Case 1 A 37 year old woman had been given a diagnosis of type 1 diabetes when she was 7 years old. She was treated with soluble insulin twice daily. She was transferred to our diabetes unit in 2000. She had experienced problems with fluctuating blood glucose concentrations, recurrent hyperglycaemia, and frequent unpredictable hypoglycaemia, despite compliance with diet and regular self monitoring of blood glucose. At her most recent annual review she was noted to have mild background retinopathy but no other microvascular or macrovascular complications of diabetes. Results of lipid, urea and electrolytes, and thyroid function tests were normal, but her glycated haemoglobin was 9.1% (normal range 3.6% to 5.1%). She was treated with Human Actrapid (Novo Nordisk) at a …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude
WALLACE, T. M. (2000) · QJM · doi:10.1093/qjmed/93.6.369 · Cited by 166 · cited 1×
“The reasons for poor glycaemic control are many; and despite insulin treatment many patients with diabetes have poor glycaemic control.”
Background
Cited by
New insulin delivery recommendations
Frid, A. H., Kreugel, G., Grassi, G., Halimi, S., Hicks, D., Hirsch, L. J., Smith, M. J., Wellhoener, R., Bode, B. W., Hirsch, I. B., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.06.010 · Cited by 286
Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes
Blanco, M., Hernández, M. T., Strauss, K. W., & Amaya, M. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.05.006 · Cited by 276
Famulla, S., Hövelmann, U., Fischer, A., Coester, H.-V., Hermanski, L., Kaltheuner, M., Kaltheuner, L., Heinemann, L., Heise, T., & Hirsch, L. (2016) · Diabetes Care · doi:10.2337/dc16-0610 · Cited by 173
Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region
Nosek, L., Coester, H.-V., Roepstorff, C., Thomsen, H. F., Kristensen, N. R., Haahr, H., & Heise, T. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0218-x · Cited by 42
Metadata
- Authors
- Chowdhury, T. A., & Escudier, V.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2003-08-14
- Volume
- 327
- Issue
- 7411
- Pages
- 383-384
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2026625607
- Cited by
- 103
- References
- 1
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.